Trough dabrafenib plasma concentrations can predict occurrence of adverse events requiring dose reduction in metastatic melanomaMarine Rousset, Mathiéu Molimard, Mireille Canal‐Raffin et al.|Clinica Chimica Acta|2017Cited by 36